0000000000919379
AUTHOR
Ferrante A
showing 29 related works from this author
Disfunzione diastolica in pazienti affetti da artrite reumatoide:ruolo della terapia con anti-TNF
2006
Le Spondiloartriti.
2004
Efficacia e sicurezza del trattamento con inibitori del TNF in pazienti affetti da spondilite anchilosante: uno studio osservazionale a 2 anni.
2006
Aterosclerosi e artrite reumatoide: ruolo della twerapia biologica
2005
Associazione tra spondiloartrite e gammopatia monoclonale: tre casi clinici
2006
La determinazione degli anticorpi antipeptide, C citrullinato è utile nel discriminare pazienti con artrite reumatoide da quelli con poliartrite asso…
2005
Ruolo della terapia con aspirina e con immunoglobuline endovena nella poliabortività associata a sindrome da anticorpi anti-fosfolipidi
2005
Malattia di KiKuchi-Fujimoto e lupus eritematoso sistemico: quale connessione ?.
2004
Iniezione locale di infliximab nel trattamento della dattilite
2005
Micofenolato mofetil nell’alveolite sclerodermica: uno studio pilota
2006
IBD e malattie reumatiche. Malattia di Crohn e spondilite anchilosante: una patogenesi comune?
2006
Atherosclerosis in females patients with rheumatoid arthritis; a two years follow-up.
2005
Terapia delle uveiti
2006
DIASTOLIC DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TNF BLOCKING AGENTS
2006
La gestione farmacologica dei pazienti con malattie reumatologiche nell’insufficienza renale
2006
Efficacia e sicurezza di infliximab nelle spondiloartriti indifferenziate: follow-up a 2 anni
2005
Atherosclerosis in female patients with rheumatoid arthritis: a two years of follow up
2005
Disfunzione diastolica in pazienti affetti da artrite reumatoide: ruolo della terapia con anti-TNFα
2006
pentoxifylline inhibits vgamma9/vdelta2 t lymphocyte activation of patients with active behçet's disease
2007
The aim ofthis study is to evaluate the in vitro effect ofpentoxifylline (PTX) on T Vy9No21ymphocyte function in Beheet's disease (DO). We investigated the effect of PTX on Vy9No2 T cell expansion and expression of TNFRII receptor and perforin content before and after PTX addition by means of FACS analysis lymphocyte cultures from patients with active and inactive DO and healthy subjects. The addition of PTX at a concentration of 1 mg/ml determined a significant inhibition of cell expansion, a down regulation of TNF receptor expression and inhibited the PMA-induced degranulation of perforin. Taken together these data indicate that PTX is capable of interfering with Vy9No2 T cell function in…
Profilo citochinico ed espressione di STATS e SOCS nell’intestino di pazienti affetti da spondilite anchilosante
2006
THE LEVEL OF SOLUBLE GRANZYME A IS ELEVATED IN THE PLASMA AND IN THE Vgamma9/Vdelta2 T CELL CULTURE SUPERNATANTS OF PATIENTS WITH ACTIVE BEHCET'S DIS…
2004
Gramzyme A (GrA) is a serine proteinase with trypsin-like activity that is released extracellularly during the degranulation of cytotoxic cells. Among the cytotoxic cells, gamma/delta T cells participate in the early phases of the immune response and are known to express perforin and granzymes constitutively in agreement with their cytolytic pontential.GrA activity was detected using the synthetic substrate N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester in the plasma and supernatants of peripheral blood mononuclear cell cultured in the presence of Dimethylallyl pyrophosphate to obtain Vgamma9/Vdelta2 T cell expansion.Significantly high levels of GrA were found in the serum and supernat…
Impatto del trattamento precoce con infliximab + methotrexate ed alte dosi di prednisone (PDN) vs infliximab (IFX) + methotrexate (MTX) e basse dosi …
2006
Fattori prognostici e predittivi della early arthritis
2006
Rapida induzione di remissione di un caso di malattia di Vogt Koyanagi Harada recidivante dopo terapia con Infliximab
2006
The level of solubile granzyme A is elevated in the plasma and in the Vγ9/Vδ2 T cell culture supernatants of patients with active Behçet's disease.
2004
Fattori prognostici e predittivi della early arthritis (EA)
2006
Atherosclerosis in female patients with rheumatoid arthritis; a two years follow-up
2005
Impatto del trattamento precoce con infliximab + methotrexate (MTX) ed alte dosi di prednisone (PDN) vs infliximab (IFX)+methotrexate (MTX) e basse d…
2006
Detection of anti-myeloperoxidase antibodies in the serum of patients with type 1 diabetes mellitus.
1996
Anti-myeloperoxidase (anti-MPO) antibodies were detected in 34 of 88 (38%) patients with type 1 diabetes mellitus but in only 3 of 55 (5.7%) healthy subjects and in 4 of 20 patients with autoimmune disease. Specificity of anti-MPO antibodies was assessed by MPO inhibition studies. No relationship was found between the occurrence of anti-MPO and anti-thyroperoxidase antibodies. Levels of soluble intercellular adhesion molecule 1 (ICAM-1) were found to be higher in anti-MPO antibody-positive (n = 28, 508 +/- 126 ng/ml) than in anti-MPO antibody-negative (n = 58, 438 +/- 140 ng/ml: P < 0.05) patients. A state of chronic neutrophil activation has been described in diabetes mellitus. As anti-MPO…